ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS
The theme of the article is one of the most wide-spread rheumatologic diseases — juvenile arthritis (JA). It highlights main questions on epidemiology, classification, pathogenesis of the disease. Authors describe clinical symptoms of different types of JA, diagnostics and differential diagnosis. Th...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2010-11-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/977 |
id |
doaj-a6805bcbb8074ea6bc2a850897b3fd53 |
---|---|
record_format |
Article |
spelling |
doaj-a6805bcbb8074ea6bc2a850897b3fd532021-07-28T21:15:36Zeng"Paediatrician" Publishers LLC Voprosy Sovremennoj Pediatrii1682-55271682-55352010-11-019678104978ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITISE.I. Alexeeva0T.М. Bzarova1Scientific Center of Children’s Helath, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Helath, Russian Academy of Medical Sciences, MoscowThe theme of the article is one of the most wide-spread rheumatologic diseases — juvenile arthritis (JA). It highlights main questions on epidemiology, classification, pathogenesis of the disease. Authors describe clinical symptoms of different types of JA, diagnostics and differential diagnosis. There is a part of an article with information on drugs used in patients with JA and the algorithm of differentiated treatment of a disease is presented. Authors paid special attention to approaches to biological therapy, conditions for the treatment and management of patients treated with genetically engineered biological drugs.Key words: children, juvenile rheumatoid arthritis, juvenile arthritis, treatment, infliximab, adalimumab, etanercept, rituximab, abatacept, tocilizumab.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(6):78-104)https://vsp.spr-journal.ru/jour/article/view/977 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
E.I. Alexeeva T.М. Bzarova |
spellingShingle |
E.I. Alexeeva T.М. Bzarova ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS Voprosy Sovremennoj Pediatrii |
author_facet |
E.I. Alexeeva T.М. Bzarova |
author_sort |
E.I. Alexeeva |
title |
ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS |
title_short |
ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS |
title_full |
ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS |
title_fullStr |
ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS |
title_full_unstemmed |
ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS |
title_sort |
algorithm of diagnostics and treatment of juvenile arthritis |
publisher |
"Paediatrician" Publishers LLC |
series |
Voprosy Sovremennoj Pediatrii |
issn |
1682-5527 1682-5535 |
publishDate |
2010-11-01 |
description |
The theme of the article is one of the most wide-spread rheumatologic diseases — juvenile arthritis (JA). It highlights main questions on epidemiology, classification, pathogenesis of the disease. Authors describe clinical symptoms of different types of JA, diagnostics and differential diagnosis. There is a part of an article with information on drugs used in patients with JA and the algorithm of differentiated treatment of a disease is presented. Authors paid special attention to approaches to biological therapy, conditions for the treatment and management of patients treated with genetically engineered biological drugs.Key words: children, juvenile rheumatoid arthritis, juvenile arthritis, treatment, infliximab, adalimumab, etanercept, rituximab, abatacept, tocilizumab.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(6):78-104) |
url |
https://vsp.spr-journal.ru/jour/article/view/977 |
work_keys_str_mv |
AT eialexeeva algorithmofdiagnosticsandtreatmentofjuvenilearthritis AT tmbzarova algorithmofdiagnosticsandtreatmentofjuvenilearthritis |
_version_ |
1721261633315012608 |